Cargando…

Lipoprotein-Associated Phospholipase A(2) Mass and Activity and Risk of Cardiovascular Disease in a Population With High Prevalences of Obesity and Diabetes: The Strong Heart Study

OBJECTIVE: To investigate the association of lipoprotein-associated phospholipase A(2) (LpPLA(2)) mass and activity with incident cardiovascular disease (CVD) in a population with high prevalences of insulin resistance and diabetes, conditions for which epidemiological data remain sparse. RESEARCH D...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kizer, Jorge R., Umans, Jason G., Zhu, Jianhui, Devereux, Richard B., Wolfert, Robert L., Lee, Elisa T., Howard, Barbara V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2012
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3308309/ https://www.ncbi.nlm.nih.gov/pubmed/22338104 http://dx.doi.org/10.2337/dc11-1639

Ejemplares similares

Hemoglobin A(1c), Fasting Glucose, and Cardiovascular Risk in a Population With High Prevalence of Diabetes: The Strong Heart Study
por: Wang, Hong, et al.
Publicado: (2011)

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk
por: Colley, Kenneth J., et al.
Publicado: (2011)

Insulin Resistance, Incident Cardiovascular Diseases, and Decreased Kidney Function Among Nondiabetic American Indians: The Strong Heart Study
por: Zhang, Ying, et al.
Publicado: (2013)

Metabolic Profiles of Obesity in American Indians: The Strong Heart Family Study
por: Zhao, Qi, et al.
Publicado: (2016)

Lack of Reduction of Left Ventricular Mass in Treated Hypertension: The Strong Heart Study
por: de Simone, Giovanni, et al.
Publicado: (2013)

Risk Factors and Prediction of Stroke in a Population with High Prevalence of Diabetes: The Strong Heart Study
por: Wang, Wenyu, et al.
Publicado: (2017)

Lipoprotein-Associated Phospholipase A2 Activity Predicts Cardiovascular Events in High Risk Coronary Artery Disease Patients
por: Maiolino, Giuseppe, et al.
Publicado: (2012)

Cardiovascular Characteristics in Subjects With Increasing Levels of Abnormal Glucose Regulation: The Strong Heart Study
por: Capaldo, Brunella, et al.
Publicado: (2013)

Lipoprotein-Associated Phospholipase A2 Is Associated with Atherosclerotic Stroke Risk: The Northern Manhattan Study
por: Katan, Mira, et al.
Publicado: (2014)

Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study
por: Lee, Jennifer S., et al.
Publicado: (2017)

Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
por: Jensen, Paul N., et al.
Publicado: (2022)

Randomly and Non-Randomly Missing Renal Function Data in the Strong Heart Study: A Comparison of Imputation Methods
por: Shara, Nawar, et al.
Publicado: (2015)

Trends in Cardiovascular Disease Morbidity and Mortality in American Indians Over 25 Years: The Strong Heart Study
por: Muller, Clemma J., et al.
Publicado: (2019)

Arsenic Exposure, Arsenic Metabolism, and Incident Diabetes in the Strong Heart Study
por: Kuo, Chin-Chi, et al.
Publicado: (2015)

Large Cohort Data Based Cost-Effective Disease Prevention Design Strategy: Strong Heart Study
por: Wang, Wenyu, et al.
Publicado: (2018)

Large Cohort Data Based Group or Community Disease Prevention Design Strategy: Strong Heart Study
por: Wang, Wenyu, et al.
Publicado: (2018)

Associations of Diet Soda and Non-Caloric Artificial Sweetener Use with Markers of Glucose and Insulin Homeostasis and Incident Diabetes: the Strong Heart Family Study
por: Jensen, Paul N., et al.
Publicado: (2019)

Fasting Plasma Glucose and Hemoglobin A(1c) in Identifying and Predicting Diabetes: The Strong Heart Study
por: Wang, Wenyu, et al.
Publicado: (2011)

Depressed Myocardial Energetic Efficiency Increases Risk of Incident Heart Failure: The Strong Heart Study
por: Losi, Maria-Angela, et al.
Publicado: (2019)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Is lipoprotein-associated phospholipase A(2) correlated with cardiovascular risk in European women?
por: Hirschler, V.
Publicado: (2013)

Epigenetic Biomarkers of Lead Exposure and Cardiovascular Disease: Prospective Evidence in the Strong Heart Study
por: Lieberman‐Cribbin, Wil, et al.
Publicado: (2022)

Cardiac Geometry and Function in Diabetic or Prediabetic Adolescents and Young Adults: The Strong Heart Study
por: De Marco, Marina, et al.
Publicado: (2011)

Association of diabetes and cancer mortality in American Indians: the Strong Heart Study
por: Best, Lyle G., et al.
Publicado: (2015)

Association of lipoprotein‐associated phospholipase A2 mass with asymptomatic cerebral artery stenosis
por: Wang, Youxin, et al.
Publicado: (2018)

Genetic and other factors determining mannose-binding lectin levels in American Indians: the Strong Heart Study
por: Best, Lyle G, et al.
Publicado: (2009)

Target organ damage and incident type 2 diabetes mellitus: the Strong Heart Study
por: de Simone, Giovanni, et al.
Publicado: (2017)

Body composition and arsenic metabolism: a cross-sectional analysis in the Strong Heart Study
por: Gribble, Matthew O, et al.
Publicado: (2013)

Myocardial mechano-energetic efficiency and insulin resistance in non-diabetic members of the Strong Heart Study cohort
por: Mancusi, Costantino, et al.
Publicado: (2019)

Genetic analysis of hsCRP in American Indians: The Strong Heart Family Study
por: Best, Lyle G., et al.
Publicado: (2019)

Short leukocyte telomere length is associated with obesity in American Indians: The strong heart family study
por: Chen, Shufeng, et al.
Publicado: (2014)

Circulating sphingolipids, fasting glucose, and impaired fasting glucose: The Strong Heart Family Study
por: Jensen, Paul N., et al.
Publicado: (2018)

Lipoprotein‐associated phospholipase A2: The story continues
por: Huang, Fubao, et al.
Publicado: (2019)

Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
por: Lemaitre, Rozenn N., et al.
Publicado: (2018)

Urine Arsenic Concentrations and Species Excretion Patterns in American Indian Communities Over a 10-year Period: The Strong Heart Study
por: Navas-Acien, Ana, et al.
Publicado: (2009)

Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease
por: Cen, Jin-Ming, et al.
Publicado: (2015)

Linkage study of fibrinogen levels: the Strong Heart Family Study
por: Best, Lyle G, et al.
Publicado: (2008)

Impact of biological aging on arterial aging in American Indians: findings from the Strong Heart Family Study
por: Peng, Hao, et al.
Publicado: (2016)

Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease
por: Doody, Rachelle S., et al.
Publicado: (2015)

Short leukocyte telomere length predicts incidence and progression of carotid atherosclerosis in American Indians: The Strong Heart Family Study
por: Chen, Shufeng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fvaqlu2cjh455rjq56jfbraned